[June 21, 2017]

Global Gastrointestinal Agents Market to Reach $21 Billion by 2025 - Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players & Competitive Strategies - Research and Markets

Research and Markets has announced the addition of the "Global Gastrointestinal agents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report to their offering.

The global gastrointestinal agents market was valued at US$ 17.2 billion in 2016, and is expected to reach US$ 21.1 billion by 2025, expanding at a CAGR of 2.6% from 2017 to 2025.

Medications for gastrointestinal diseases and symptoms include prescription and nonprescription drugs, conventional and unconventional agents, simple small molecules, complex macromolecules and large recombinant proteins. These medications can be classified based upon their use: drugs for nausea and vomiting (antiemetics), prokinetic agents, laxatives, antidiarrheal agents, drugs for acid peptic disease, drugs for irritable bowel syndrome, inflammatory bowel disease and, of course, miscellaneous. Gastrointestinal disorders include conditions such as cnstipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer. Many of these can be prevented or minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.

The global gastrointestinal agents market is segmented by drug type as antidiarrheal, anti-ulcers, laxatives, inflammatory bowel disease drugs and irritable bowel syndrome drugs. Among these, inflammatory bowel disease held the largest share in the gastrointestinal agents market due high prevalence of inflammatory bowel disease in the region.

Companies Mentioned:

• Abbott Laboratories
  
• Allergan Plc. (Formerly Actavis Plc.)
  
• Astrazeneca
  
• Bayer Ag
  
• Boehringer Ingelheim Gmbh
  
• Glaxosmithkline Plc
  
• Janssen Biotech, Inc
  
• Ranbaxy Laboratories Limited
  
• Sanofi
  
• Takeda Pharmaceutical
  
• Valeant Pharmaceuticals, Inc
  

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Global Gastrointestinal Agents Market Analysis

Chapter 4 Gastrointestinal Agents Market Analysis, by Drug Class, 2015-2025 (US$ Mn)

Chapter 5 Americal Gastrointestinal Agents Market, by Geography, 2015-2025 (US$ Mn)

Chapter 6 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/bpkprf/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20170621005777/en/

[ Back To TMCnet.com's Homepage ]